The Themes Heart & Health ETF is an active thematic fund that selects companies involved in the prevention and treatment of conditions requiring long-term management, such as heart disease, diabetes, and obesity. Rather than mechanically tracking a specific index, it chooses holdings based on structural changes in the relevant businesses and on company-specific conditions.

It suits investors with a long-term interest in cardiometabolic health and innovation in the prevention and treatment of chronic disease, who are willing to accept theme-concentrated exposure rather than a broad index.

This is an actively managed ETF run by Themes ETF.

The manager evaluates growth potential, business models, competitiveness, and financial condition across groups of companies tied to heart health, metabolic disease, and weight management. Unlike a fund that simply holds the constituents of an index, it is an active strategy that adjusts position weights and composition to reflect industry changes and company-level judgment.

• Thematic design focused on heart health and metabolic disease
• A selection process that combines bottom-up company analysis with a macro perspective

Assets under management (AUM) stand at $55.1M, and the expense ratio is 0.75% per year.

As a micro-cap fund, its trading conditions and bid-ask spreads should be checked before placing an order. It is also worth comparing its fee level with broad healthcare funds and considering the cost impact over a long holding period.

Demand for the prevention and treatment of chronic disease and research and development on weight management therapies are the key points of interest for this theme. However, the performance of the HRTS ETF can vary widely depending on the commercialization of medical technology, clinical trial results, regulatory decisions, and individual company earnings, so it may move differently from the broader healthcare sector.

Fund flows may be more sensitive to market expectations and risk appetite for the heart health and metabolic disease theme than to defensive healthcare stocks as a whole. Because the fund is classified as a micro-cap product, investors should monitor changes in trading conditions and in fund inflows and outflows, and assess how the theme concentration may affect the overall portfolio.

Selective exposure to disease prevention and treatment innovation is a strength, but investors must accept the volatility that comes with theme concentration and active stock selection.

In the comparison table, the DRAM ETF focuses on the memory industry, the SECT ETF on sector rotation, and the AVRE ETF on real estate. The VOLT ETF covers the electrification theme and the CANC ETF covers the oncology theme, so their holdings and disease coverage differ directly from those of the HRTS ETF. These funds differ in fees, asset size, and theme concentration, so they can serve as a supplementary reference for comparing thematic exposure inside and outside healthcare. Information on other listed funds in a similar category is limited, so judgment should center on the purpose and risks of the HRTS ETF.

When evaluating the Themes Heart & Health ETF, start by looking at which disease themes it concentrates on compared with broad healthcare investing. Unlike index-tracking products, the HRTS ETF is heavily influenced by the manager's company selection decisions, so it is important to review its selection principles and risk factors together.

Medical innovation themes can be affected by research and development, clinical trial results, regulatory decisions, patents, and the competitive environment. The HRTS ETF has a non-diversified structure, so assets may be concentrated in a limited number of industries or issuers, and its trading conditions and price volatility as a micro-cap fund should also be considered.

The Themes Heart & Health ETF is an active healthcare fund focused on innovation in the prevention and treatment of chronic disease. Before holding it for the long term, investors should review how its role differs from broad healthcare funds, along with its distribution policy, management fee, and theme concentration risk. The HRTS ETF may serve its purpose best when approached as a supplementary thematic exposure within a portfolio.